Altimmune, Inc. — Director's Dealing 2020

Feb 14, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2019-07-12

Reporting Person: VELOCITY PHARMACEUTICAL HOLDINGS LLC (10% Owner)
Reporting Person: Collier David J (10% Owner)
Reporting Person: Watson James F (10% Owner)
Reporting Person: Velocity Pharma Management, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1887250	Direct

Footnotes

F1: The shares are directly held by Velocity Pharmaceutical Holdings LLC ("VPH"). Velocity Pharma Management, LLC ("VPM") is the manager of VPH. David J. Collier and James F. Watson are the managing members of VPM, and as such may be deemed to hold shared voting and dispositive power over the shares held by VPH. Mr. Collier and Mr. Watson disclaim beneficial ownership of the shares held by VPH except to the extent of their pecuniary interest therein.